2025-12-03 - Analysis Report
Here's a comprehensive analysis of Northrop Grumman (NOC) based on the provided data:

**0) Overview**

*   **Ticker:** NOC
*   **Company Name:** Northrop Grumman Corp
*   **Company Overview:** Northrop Grumman is a global aerospace and defense technology company.

**1) Return Rate Comparison**

*   **NOC Cumulative Return:** 42.05%
*   **VOO (S&P 500) Cumulative Return:** 100.36%
*   **Divergence:** -53.7% (current), Range: -57.2% to 56.8%, Relative Divergence: 3.1%

**Analysis:** NOC has significantly underperformed the S&P 500 over the period examined. The divergence is currently at -53.7%, which puts it near the low end of its historical divergence range compared to VOO (relative divergence of 3.1%).

**Alpha, Beta Analysis:**

| Year       | CAGR     | MDD     | Alpha   | Beta  | Cap(B) |
|------------|----------|---------|---------|-------|--------|
| 2015-2017  | 46.0%    | 65.6%   | 17.0%   | 0.0   | 44.0   |
| 2016-2018  | -2.0%    | 74.3%   | -17.0%  | 0.0   | 35.1   |
| 2017-2019  | 17.0%    | 79.2%   | -5.0%   | 0.9   | 49.3   |
| 2018-2020  | -28.0%   | 79.9%   | -52.0%  | 0.8   | 43.6   |
| 2019-2021  | 43.0%    | 79.9%   | -4.0%   | 0.8   | 55.5   |
| 2020-2022  | 18.0%    | 79.9%   | 19.0%   | 0.3   | 78.2   |
| 2021-2023  | 24.0%    | 82.7%   | 23.0%   | 0.2   | 67.1   |
| 2022-2024  | -15.0%   | 82.7%   | -36.0%  | 0.2   | 67.2   |
| 2023-2025  | -9.0%    | 82.1%   | -73.0%  | 0.1   | 78.4   |

*   **CAGR:** Fluctuates significantly year to year, showing periods of high growth and substantial decline.
*   **MDD:** High Maximum Drawdown values indicate substantial risk and volatility.
*   **Alpha:** Often negative, especially in recent periods, meaning NOC has frequently underperformed its benchmark. Positive alpha in 2015-2017, 2020-2022, and 2021-2023.
*   **Beta:** Generally low, indicating that NOC is less sensitive to market movements than the overall market.
*   **Cap(B):** Market Cap.

**2) Recent Stock Price Fluctuations**

*   **Current Close:** 547.46
*   **Last Market Data:** Price: 547.73, Previous Close: 545.51, Change: 0.41
*   **5-day SMA:** 564.36
*   **20-day SMA:** 565.59
*   **60-day SMA:** 585.80

**Analysis:** The stock price is currently below its 5, 20, and 60-day Simple Moving Averages, suggesting a potential short-term downtrend. The marginal increase from the previous close could indicate minor positive momentum or consolidation.

**3) Technical Indicators & Expected Return**

*   **Market Risk Indicator (MRI):** 0.9 (Medium Investment Recommended)
*   **RSI:** 37.73 (Approaching oversold territory)
*   **PPO:** 0.07
*   **Hybrid Signal:** Buy 100% of cash (4 shares - Very Safe - MRI:0.90)
*   **Recent Relative Divergence Change:** -6.8 (Short-term decline)
*   **Expected Return:** -212.7% (Negative expected excess return compared to S&P 500)

**Analysis:** The MRI suggests a medium investment recommendation, despite the negative expected return. The RSI approaching oversold territory (below 30) could indicate a potential buying opportunity for short-term traders, although the substantial negative expected return highlights significant long-term concerns. Recent decline and change in the relative divergence confirm the short-term downturn.

**4) Recent News & Significant Events**

*   **Negative:**
    *   Lumbard & Kellner LLC Reduces Stock Holdings in Northrop Grumman Corporation.
    *   Northrop Grumman is Now Oversold.
*   **Positive/Neutral:**
    *   BNP Paribas Has a Positive Outlook on Northrop Grumman.
    *   Has Northrop Grumman’s Recent Pullback Created a New Opportunity for Investors?
    *   1 Safe-and-Steady Stock with Promising Prospects and 2 We Question (may or may not be directly positive, depending on the full article).

**Analysis:** News is mixed. Negative headlines highlight selling pressure and oversold conditions. Positive headlines focus on analyst upgrades and potential opportunities from the pullback.

**4-2) Analyst Opinions**

*   **Consensus:** Buy (2.10 on a scale where 1=Strong Buy, 5=Sell)
*   **Target Price (avg/high/low):** 667.21 / 770.00 / 533.00

**Analysis:** Despite recent performance and negative expected return, analyst consensus remains positive with a Buy rating. The average target price of $667.21 suggests significant upside potential from the current price, but also highlights a wide range of opinions given the large difference between high and low targets.

**5) Recent Earnings Analysis**

| 날짜       | EPS   | 매출          |
|------------|-------|---------------|
| 2025-10-21 | 7.69  | 10.42 B$      |
| 2025-07-22 | 8.17  | 10.35 B$      |
| 2025-04-22 | 3.33  | 9.47 B$       |
| 2024-10-24 | 7.02  | 10.00 B$      |
| 2025-10-21 | 7.02  | 10.00 B$      |

**Analysis:** Revenue is relatively consistent, but EPS has fluctuated.

**6) Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
|------------|-----------|---------------|
| 2025-09-30 | $10.42B   | 21.37%        |
| 2025-06-30 | $10.35B   | 21.35%        |
| 2025-03-31 | $9.47B    | 16.69%        |
| 2024-12-31 | $10.69B   | 18.08%        |
| 2024-09-30 | $10.00B   | 21.07%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE    |
|------------|-----------|--------|
| 2025-09-30 | $15.99B   | 6.88%  |
| 2025-06-30 | $15.47B   | 7.59%  |
| 2025-03-31 | $14.98B   | 3.21%  |
| 2024-12-31 | $15.29B   | 8.27%  |
| 2024-09-30 | $14.75B   | 6.96%  |

**Analysis:** Revenue has been relatively stable, with a slight dip in the quarter ending March 31, 2025. Profit margins have remained strong, generally above 21%, with the exception of the March 2025 quarter. Equity has been steadily increasing. ROE has fluctuated, with the lowest value in March 2025.

**7) Comprehensive Analysis (Summary)**

Northrop Grumman (NOC) presents a mixed picture.

*   **Negatives:**
    *   Significant underperformance compared to the S&P 500.
    *   Negative expected return (-212.7%) suggests caution for long-term investors based on current data.
    *   Recent negative divergence and price below moving averages indicate a short-term downtrend.
    *   News headlines highlighting oversold conditions and reduced stock holdings.
*   **Positives:**
    *   Analyst consensus remains a "Buy" with a target price significantly higher than the current price.
    *   Strong and relatively consistent revenue.
    *   Reasonable Profit Margins.
    *   RSI nearing oversold territory could present a short-term trading opportunity.
    *   Market Risk Indicator suggests a medium investment.

**Overall, the investment decision hinges on risk tolerance and investment horizon.** Short-term traders might see an opportunity in the oversold conditions and analyst target prices. However, long-term investors should carefully consider the underperformance relative to the S&P 500 and the negative expected return, weighing it against the analyst bullishness and the company's underlying financial stability and profitability. The recent underperformance and negative expected return should raise concerns that need to be addressed by further due diligence.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.